Ultra-sensitive immunoassays using multi-photon-detection in diagnostic proteomics of blood

Journal of Proteome Research

Volumn 4, Issue 6, 2005, Pages 2375-2378

  Drukier, Andrzej K ^a   Ossetrova, Natascha ^a   Schors, Elena ^a   Brown, Larry R ^a   Tomaszewski, John ^b   Sainsbury, Richard ^c   Godovac Zimmermann, Jasminka ^c  

^a BioTraces Inc   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Blood; Breast cancer; Cytokines; Diagnostics; Growth factors; HIV 1; Immunoassay; Multiphoton detection; Proteomics; Serum

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; IODINE 125; PROSTATE SPECIFIC ANTIGEN; STREPTAVIDIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ATOM; BLOOD ANALYSIS; BREAST CANCER; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOASSAY; MALE; MULTIPHOTON DETECTION; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ASSAY; SERUM; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; AUTOMATION; BIOLOGICAL MARKERS; BIOTINYLATION; BLOOD PROTEINS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV-1; HUMANS; IMMUNOASSAY; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; PHOTONS; PROSTATE-SPECIFIC ANTIGEN; PROTEOME; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 29144460192     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr050320n     Document Type: Article

References (12)

1. Rosenblatt, K. P.; Bryant-Greenwood, P.; Killian, J. K.; Mehta, A.; Geho, D.; Espina, V.; Petricoin, E. F., 3rd; Liotta, L. A. Serum proteomics in cancer diagnosis and management. Annu. Rev. Med. 2004, 55, 97-112.
2. Kleiner, O.; Godovac-Zimmermann, J. "Proteomics of Signal Transduction Pathways." In. Signaling Pathways in Liver Diseases; Dufour, J.-F., Clavien, P.-A., Eds.; Springer-Verlag: Heidelberg, 2005, pp 417-431.
3. Rai, A. J.; Chan, D. W. Cancer proteomics: Serum diagnostics for tumor marker discovery. Ann. NY Acad. Sci. 2004, 1022, 286-294.
4. Conrads, T. P.; Hood, B. L.; Issaq, H. J.; Veenstra, T. D. Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool. Mol. Diagn. 2004, 8, 77-85.
5. Godovac-Zimmermann, J.; Brown, L. R. Perspectives for mass spectrometry and functional proteomics. Mass Spectrom. Rev. 2001, 20, 1-57.
6. Zhu, H.; Bilgin, M.; Snyder, M. Proteomics. Annu. Rev. Biochem. 2003, 72, 783-812.
7. http://www.wipo.int patent WO01/081924.
8. Kleiner, O.; Price, D. A.; Ossetrova, N.; Osetrov, S.; Volkovitsky, P.; Drukier, A. K.; Godovac-Zimmermann, J. Ultrahigh sensitivity multiphoton-detection imaging in proteomics. analyses. Proteomics 2005, 5, 2322-2330.
9. Sainsbury, R.; Godovac-Zimmermann, J.; Drukier, A. K.; Tomaszewski, J.; Kleiner, O. Serum PSA, IL6 and TNF predict likelihood of breast cancer. Breast Canc. Res. Tr. 2004, 88, S220-221 Suppl. 1.
10. Duffy, M. J. PSA as a marker for prostate cancer: a critical review. Ann. Clin. Biochem. 1996, 33, 511-519.
11. Recker, F.; Kwiatowski, M. K.; Huber, A.; Stamm, B.; Lehmann, K.; Tscholl, R. Prospective detection for clinically relevant prostate cancer in the prostate-specific antigen range 1 to 3 ng/mL, combined with free-to-total ratio 20% or less: the Aarau experience. J. Urol. 2001, 165, 851-855.
12. Brawer, M. K. Prostate Specific Antigen. Semin. Surg. Oncol. 2000, 18, 3-9.